Skip to main content
BAXTER INTERNATIONAL INC logo

BAXTER INTERNATIONAL INC — Investor Relations & Filings

Ticker · BAX ISIN · US0718131099 LEI · J5OIVXX3P24RJRW5CK77 US Manufacturing
Open in API
Filings indexed 2,456 across all filing types
Latest filing 2021-07-29 Capital/Financing Update
Country US United States of America
Listing US BAX

About BAXTER INTERNATIONAL INC

https://www.baxter.com/

Baxter International Inc. is a global healthcare company focused on saving and sustaining lives. The company provides a broad portfolio of essential products across renal care, hospital, and surgical settings. Key offerings include technologies for acute and chronic dialysis, sterile intravenous (IV) solutions, infusion systems, clinical nutrition, and critical care. Baxter develops, manufactures, and markets a range of medical devices, connected care solutions, and advanced injectable pharmaceuticals. The company's products are used by healthcare professionals in hospitals, clinics, and homes to provide smarter, more personalized care for patients.

Recent filings

Filing Released Lang Actions
S-3ASR
Capital/Financing Update Classification · 95% confidence The document is a Form S-3 registration statement filed with the SEC by Baxter International Inc. It is a registration statement under the Securities Act of 1933, used for registering securities for sale to the public. The text includes details about the securities being registered (common stock, preferred stock, debt securities, warrants, units), the registration fee calculation, and a prospectus describing the offering. This is not a financial report, earnings release, or management discussion, but a capital markets filing related to securities issuance. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it is the actual registration statement, not just an announcement of a report, so it is not RPA or RNS. Confidence is high given the clear identification of the form and content.
2021-07-29 English
10-Q
Interim / Quarterly Report Q2 2021
2021-07-29 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated July 29, 2021, reporting the issuance of an earnings press release for the period ended June 30, 2021. The text explicitly states that the press release is furnished as an exhibit to the report. The document itself is short (3419 characters) and primarily serves to announce the earnings release rather than containing detailed financial statements or analysis. According to the 'Menu vs Meal' rule, such a document is an announcement of a report (earnings press release) rather than the report itself. Therefore, the correct classification is Earnings Release (ER).
2021-07-29 English
FORM 4 SUBMISSION
Director's Dealing
2021-06-25 English
FORM 3 SUBMISSION
Director's Dealing
2021-06-24 English
SD
Regulatory Filings Classification · 95% confidence The document is a Form SD filed with the SEC, specifically a Specialized Disclosure Report related to conflict minerals for the reporting period January 1 to December 31, 2020. It references the Conflict Minerals Report as an exhibit and includes regulatory compliance information under Rule 13p-1 of the Securities Exchange Act. The document is 3834 characters long, which is relatively short and primarily serves as a disclosure filing rather than a full financial or management report. It does not contain financial statements or detailed analysis but rather a regulatory disclosure about conflict minerals sourcing and due diligence. Therefore, it fits the category of Regulatory Filings (RNS), which is the fallback for specialized regulatory disclosures that do not fit other categories like Annual Report or Environmental & Social Information.
2021-06-01 English

Browse filings by year

33 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.